This item requires a subscription to Journal of Clinical Oncology.

PDF Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic... Demetri et al. J Clin Oncol.2009; 27: 3141-3147 To view this item, select one of the options below: Sign In User Name Sign in without cookies. Can't get past this page? Help with Cookies. Need to Activate? Password Remember my user name & password. Forgot your user name or password? Login via Athens or your institution Sign Up Subscribe to the Journal - Subscribe to the print and/or online journal. Order Online - Purchase your subscription online. [regain access to your recent online order] Renew Online - Renew your subscription online. [regain access to your recent online renewal] Purchase JCO Legacy Archive - [More Information] [regain access to your recent online Legacy Archive order]

This Article Abstract Full Text (HTML) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Google Scholar Articles by Demetri, G. D. Articles by von Mehren, M. PubMed PubMed Citation Articles by Demetri, G. D. Articles by von Mehren, M. Social Bookmarking                            What's this?